The average one-year price target for Vincerx Pharma (NASDAQ:VINC) has been revised to 7.14 / share. This is an increase of 10.53% from the prior estimate of 6.46 dated October 31, 2023. The price ...
Vincerx Pharma, Inc. (VINC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Vincerx Pharma Inc (NASDAQ:VINC) shares are trading lower by 9.7% to $0.81 during Friday’s session after the company priced an underwritten public offering, including 6 million shares of common stock ...
Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance of ...
Find the latest Vincerx Pharma, Inc. VINC analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results